Interleukin-2 Injection for Melanoma Therapy from Canada
Recombinant human IL-2 in single-dose vials for retail, an immunological cytokine stimulating T-cell response in cancer immunotherapy. HTS 3002.15.00.91 applies as it matches chapter note for interleukins as immunological products in measured retail packs.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide stability data for shipping; IL-2 degrades above 8°C, risking total loss
• Declare as 'biotech-derived' to support immunological classification
• Watch for reclassification if sold in multi-dose bulk for hospitals